Standards & Regulation

As incidents of DEG poisoning continue to occur, the IPEC Federation issues a call for companies not to be complacent when it comes to supply chains.

Three regulatory pathways for drug–device combinations – and why early action is key.

Introducing the British Standards Institution’s new environmental initiative to minimize antimicrobial resistance caused by manufacturing operations.

A drug development story: how one company filed a marketing authorization in Europe for a botanical drug to treat alopecia areata.

A look at the FDA’s safety investigation into CAR T therapeutics.

As the Sunshine State looks to import medicines to lower costs for Floridians, what of ongoing shortages for Canadians?

A video tour of the top FDA approvals from 2023

The details and reactions behind a recent FDA investigation into the cancer-risk of CAR-T therapies

How do we encourage the development of new cell and gene therapies without compromising our ethics?

Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either